Citigroup raises AbbVie target price to $295 from $260
ABBV•Citigroup raised its target price for AbbVie to $295 from $260.
Related News
Callan JMB expects up to $15 million in oral thin-film revenue in first 18 months of operation
CJMB•
Marriott lifts annual room revenue growth forecast on resilient travel demand
MAR•
SiteOne Landscape Supply acquires Bedrock Environmental Seed & Supply
SITE•
Rectitude agrees to acquire Mr. Butler for 800,000 shares
RECT•
Innventure says it will not raise full $60 million under at-the-market offering
INV•